Capital Advisory Group Advisory Services’s Moderna MRNA Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-86	Closed	-$15K	–	374
2022 Q1	$15K	Buy	+86	New	+$14.5K	0.01%	327
2021 Q4	–	Sell	-80	Closed	-$31K	–	366
2021 Q3	$31K	Sell	80 -48	-38%	-$17.7K	0.01%	290
2021 Q2	$30K	Hold	128	–	–	0.01%	294
2021 Q1	$17K	Hold	128	–	–	0.01%	326
2020 Q4	$13K	Hold	128	–	–	0.01%	342
2020 Q3	$9K	Buy	+128	New	+$8.93K	﹤0.01%	326

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Advisory Group Advisory Services's MRNA Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Moderna (MRNA) in Q2 2022, closing a stake of 86 shares — an estimated $15K sold.

Capital Advisory Group Advisory Services first reported a position in MRNA in Q3 2020 and held it in 6 quarters. The position peaked at $31K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

Capital Advisory Group Advisory Services reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 86 Moderna shares in Q2 2022, an estimated $15K.
Capital Advisory Group Advisory Services first reported a position in Moderna in Q3 2020 and held it in 6 quarters.
Capital Advisory Group Advisory Services's Moderna position peaked at $31K in Q3 2021.
981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.